CryoLife, Inc. engages in the development and commercialization of biomaterials and implantable medical devices. Its biomaterials and implantable devices include BioGlue surgical adhesive, porcine heart valves, and vascular grafts of bovine tissue. The company’s product BioGlue, a polymer based on bovine blood protein and an agent for cross-linking proteins, is designed for cardiovascular, vascular, pulmonary, and general surgical applications, as well as used as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels. It markets BioGlue to physicians and distributes it through its technical representatives in the United States and Europe, as...